These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21573833)

  • 21. [Differentiated thyroid carcinoma: survival and prognostic factors].
    Sastre Marcos J; Llamazares Iglesias O; Vicente Delgado A; Marco Martínez A; Cánovas Gaillemin B; Orradre Romero JL; Morlan López MÁ; López López J
    Endocrinol Nutr; 2011 Apr; 58(4):157-62. PubMed ID: 21419724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.
    Keegan TH; Grogan RH; Parsons HM; Tao L; White MG; Onel K; Horn-Ross PL
    Thyroid; 2015 Jun; 25(6):635-48. PubMed ID: 25778795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients.
    Mei X; Yao X; Feng F; Cheng W; Wang H
    BMC Cancer; 2021 May; 21(1):543. PubMed ID: 33980182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece.
    Tzavara I; Vlassopoulou B; Alevizaki C; Koukoulis G; Tzanela M; Koumoussi P; Sotsiou F; Thalassinos N
    Clin Endocrinol (Oxf); 1999 May; 50(5):643-54. PubMed ID: 10468931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up.
    Vassilopoulou-Sellin R; Goepfert H; Raney B; Schultz PN
    Head Neck; 1998 Sep; 20(6):549-55. PubMed ID: 9702543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 28. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
    Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
    Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deaths related to differentiated thyroid cancer: a rare but real event.
    Leite AKN; Cavalheiro BG; Kulcsar MA; Hoff AO; Brandão LG; Cernea CR; Matos LL
    Arch Endocrinol Metab; 2017; 61(3):222-227. PubMed ID: 28699989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines.
    Nguyen XV; Roy Choudhury K; Tessler FN; Hoang JK
    Thyroid; 2018 Mar; 28(3):295-300. PubMed ID: 29373949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery. Comparison with a control group.
    García-Pascual L; Balsells M; Fabbi M; Pozo CD; Valverde MT; Casalots J; González-González JM; Veloso E; Anglada-Barceló J
    Endocrine; 2011 Dec; 40(3):423-31. PubMed ID: 21541652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies.
    Pasqual E; Schonfeld S; Morton LM; Villoing D; Lee C; Berrington de Gonzalez A; Kitahara CM
    J Clin Oncol; 2022 May; 40(13):1439-1449. PubMed ID: 35044839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
    Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH
    Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival of differentiated thyroid carcinoma studied in 500 patients.
    Lerch H; Schober O; Kuwert T; Saur HB
    J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
    Corrêa NL; de Sá LV; de Mello RC
    Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases.
    Bal CS; Garg A; Chopra S; Ballal S; Soundararajan R
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):745-51. PubMed ID: 25210762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult well differentiated thyroid carcinoma presenting as cervical node disease.
    Sanders LE; Rossi RL
    World J Surg; 1995; 19(4):642-6; discussion 646-7. PubMed ID: 7676714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma.
    Mazzaferri EL
    Thyroid; 1997 Apr; 7(2):265-71. PubMed ID: 9133698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.